Imatinib Mesylate for Plexiform Neurofibromas in Patients With Neurofibromatosis Type 1: A Phase 2 Trial

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(12)70414-x
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

2013English

Multiple Plexiform Neurofibromas in Neurofibromatosis Type 1: A Case Report

Journal of Medical Science And clinical Research
2018English

Management of Head and Neck Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis Type 1

Archives of Otolaryngology–Head & Neck Surgery
2005English

Phase I Clinical Trial Combining Imatinib Mesylate and IL-2

OncoImmunology
OncologyAllergyImmunology
2013English

Hypervascular Neurofibromas in a Case of Neurofibromatosis Type 1 - A Case Report

Journal of Clinical and Experimental Dentistry
Dentistry
2011English

554 Sirolimus Gel Effectively Reduced Neurofibromas in Neurofibromatosis Type 1 in a Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients With Neurofibromatosis Type 1

American Journal of Human Genetics
Genetics
2000English

Giant Plexiform Neurofibroma Causing Asymptomatic Cervical Spinal Cord Compression in a Child With Neurofibromatosis Type 1

BMJ Case Reports
Medicine
2013English

Craniofacial Plexiform Neurofibromatosis

Journal of Contemporary Dentistry
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy